Bifocal clear cell papillary renal cell tumor not associated with end-stage renal disease
DOI:
https://doi.org/10.48193/bey0w687Keywords:
Clear cell papillary renal cell tumor, end-stage kidney disease, immunohistochemistryAbstract
Clinical case description: A 63-year-old man with gastrointestinal symptoms without history of kidney disease. Through an abdominal computed axial tomography study, two lesions were detected in the right kidney that were resected. By morphology both lesions showed papillary pattern with clear cell features, low grade and fibromuscular stroma. By immunohistochemistry cytokeratin 7, cytokeratin 34βE12, carbonic anhydrase IX, PAX8, parafibromin and vimentin were positive, while CD10, AMARC, RCC, TFE3 were negative.
Clinical implications: Clear cell papillary renal cell tumor (CCPRCT) is a recognized entity that has a unique morphologic and immunohistochemical features with an indolent clinical behavior with no recurrences, metastases or lymph node involvement. It was initially described in conjunction with end-stage renal disease; however, sporadic cases have been described in patients without kidney disease. It is important to correctly differentiate from other subtypes with worse prognosis.
Relevance: CCPRCT previously called carcinoma has changed its name in the latest WHO publication (2022) due to the absence of cases with metastasis or recurrence, it is an indolent neoplasm that must be differentiated from other more aggressive tumors.
Conclusions: CCPRCT can occur in patients without history of renal disease, it has an excellent prognosis, partial or total nephrectomy is the treatment of choice. The pathologist must differentiate it from other renal cell tumors with more aggressive behavior.
References
Moch H, Amin MB, Berney DM, Compérat EM, Gill AJ, Hartmann A, et al. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours. European Urology. 2022;82(5): 458–468. https://doi.org/10.1016/j.eururo.2022.06.016.
Gobbo S, Eble JN, Grignon DJ, Martignoni G, MacLennan GT, Shah RB, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. The American Journal of Surgical Pathology. 2008;32(8): 1239–1245. https://doi.org/10.1097/pas.0b013e318164bcbb.
Zhou H, Zheng S, Truong LD, Ro JY, Ayala AG, Shen SS. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma. Human Pathology. 2014;45(1): 59–64. https://doi.org/10.1016/j.humpath.2013.08.004.
Zhao J, Eyzaguirre E. Clear Cell Papillary Renal Cell Carcinoma. Archives of Pathology & Laboratory Medicine. 2019;143(9): 1154–1158. https://doi.org/10.5858/arpa.2018-0121-rs.
Aron M, Chang E, Herrera L, Hes O, Hirsch MS, Comperat E, et al. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor. The American Journal of Surgical Pathology. 2015;39(7): 873–888. https://doi.org/10.1097/pas.0000000000000446.
Shao T, Yousef P, Shipilova I, Saleeb R, Lee JY, Krizova A. Clear cell papillary renal cell carcinoma as part of histologically discordant multifocal renal cell carcinoma: A case report and review of literature. Pathology, Research and Practice. 2016;212(3): 229–233. https://doi.org/10.1016/j.prp.2015.12.007.
Anderson DA, Tretiakova MS. Primary Renal Carcinoid with Bilateral Multiple Clear Cell Papillary Renal Cell Carcinomas. Case Reports in Pathology. 2017;2017. https://doi.org/10.1155%2F2017%2F9672368.
Shi SS, Shen Q, Xia QY, Tu P, Shi QL, Zhou XJ, et al. Clear cell papillary renal cell carcinoma: a clinicopathological study emphasizing ultrastructural features and cytogenetic heterogeneity. International Journal of Clinical and Experimental Pathology. 2013;6(12): 2936–2942.
Alexiev BA, Drachenberg CB. Clear cell papillary renal cell carcinoma: Incidence, morphological features, immunohistochemical profile, and biologic behavior: A single institution study. Pathology, Research and Practice. 2014;210(4): 234–241. https://doi.org/10.1016/j.prp.2013.12.009.
Morlote DM, Harada S, Batista D, Gordetsky J, Rais-Bahrami S. Clear cell papillary renal cell carcinoma: molecular profile and virtual karyotype. Human Pathology. 2019;91: 52–60. https://doi.org/10.1016/j.humpath.2019.05.011.
Cui C, Ziober A, Bing Z. Expression of parafibromin in clear cell papillary renal cell carcinoma. Applied immunohistochemistry & molecular morphology: AIMM. 2013;21(4): 322–325. https://doi.org/10.1097/pai.0b013e31827362c9.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Revista Mexicana de Urología
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.